Loading…
Loading…
EQUITY / NASDAQ · XNCM
Imunon Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.28 USD · 0%
Observed: Oct 2, 2026, 7:59 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 1.28 USD · Volume 94,830
681 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Operating profit | -2,791,546 USD | — | — |
| Net income | -2,814,114 USD | — | — |
| Cash and cash equivalents | 6,864,378 USD | — | — |
| Total liabilities | 10,800,326 USD | — | — |
| Total equity | 4,188,787 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 203/31/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 101/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 6,864,378 USD | — | — | 4,794,070 USD | 8,781,059 USD | 8,781,059 USD | 5,250,929 USD | — |
| Net incomeIncome statement | -2,814,114 USD | -7,063,136 USD | — | -4,249,022 USD | — | -14,495,028 USD | -3,429,124 USD | -10,272,178 USD |
| Operating profitIncome statement | -2,791,546 USD | -7,098,098 USD | — | -4,306,552 USD | — | -14,650,694 USD | -3,475,828 USD | -10,388,991 USD |
| Total assetsBalance sheet | 14,989,113 USD | — | — | 8,018,713 USD | 12,288,116 USD | 12,288,116 USD | 8,987,733 USD | — |
| Total equityBalance sheet | 4,188,787 USD | — | 3,359,631 USD | 3,359,631 USD | 7,061,876 USD | 7,061,876 USD | 4,081,724 USD | — |
| Total liabilitiesBalance sheet | 10,800,326 USD | — | — | 4,659,082 USD | 5,226,240 USD | 5,226,240 USD | 4,906,009 USD | — |
| Capital expendituresCash flow statement | — | 69,080 USD | — | — | — | 280,572 USD | — | 276,983 USD |
| Financing cash flowCash flow statement | — | 10,163,031 USD | — | -1,813 USD | — | 17,085,488 USD | — | 9,894,668 USD |
| Investing cash flowCash flow statement | — | -69,080 USD | — | — | — | -280,572 USD | — | -276,983 USD |
| Operating cash flowCash flow statement | — | -7,010,632 USD | — | -3,985,176 USD | — | -13,896,624 USD | — | -10,239,523 USD |
| Report source | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 05/12/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.